Research status and molecular mechanisms of disulfidptosis in cardiovascular diseases (Review)
Related Experiment Video
Updated: Feb 7, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Xiao Jin1, Zelin Cheng1, Xinyue Ding1
1Department of Cardiology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, P.R. China.
Abstract:
Cardiovascular diseases (CVDs) remain the primary cause of death worldwide. Exploring novel therapeutic targets is important for defining future research directions in cardiovascular medicine. Considering the notable role of cell death in disease pathogenesis, targeting disulfidptosis may represent a valuable therapeutic strategy for CVDs. However, current research increasingly centers on cancer, and the role of disulfidptosis in the cardiovascular field remains insufficiently explored. Accordingly, the present review examines the mechanisms of disulfidptosis across different cardiac cell types: Cardiomyocytes, vascular smooth muscle cells, endothelial cells and fibroblasts. Furthermore, the review discusses existing evidence for disulfidptosis in CVDs and potential intervention strategies, aiming to provide new perspectives for preventing and treating CVDs.
Insights
Disulfidptosis, a cell death pathway, is implicated in cardiovascular diseases (CVDs). Targeting this process offers a novel therapeutic strategy for CVDs, though research is currently limited in this area.
Area of Science:
- Cardiovascular Medicine
- Cell Biology
- Pathogenesis of Disease
Background:
- Cardiovascular diseases (CVDs) are the leading global cause of mortality.
- Cell death pathways play a significant role in the pathogenesis of CVDs.
- Disulfidptosis is an emerging cell death mechanism with potential therapeutic implications.
Purpose of the Study:
- To review the mechanisms of disulfidptosis in key cardiac cell types.
- To explore the role and evidence of disulfidptosis in cardiovascular diseases.
- To discuss potential therapeutic strategies targeting disulfidptosis for CVDs.
Main Methods:
- Literature review of existing research on disulfidptosis.
- Examination of disulfidptosis mechanisms in cardiomyocytes, vascular smooth muscle cells, endothelial cells, and fibroblasts.
- Analysis of current evidence linking disulfidptosis to cardiovascular pathologies.
Main Results:
- Disulfidptosis mechanisms were analyzed across various cardiac cell types.
- Evidence for disulfidptosis involvement in CVD pathogenesis was discussed.
- Potential intervention strategies targeting disulfidptosis were identified.
Conclusions:
- Disulfidptosis represents a promising, yet under-explored, therapeutic target for cardiovascular diseases.
- Further research into disulfidptosis in the cardiovascular field is warranted.
- Targeting disulfidptosis may offer novel perspectives for CVD prevention and treatment.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Marcia's Theory of Identity Status